A phase 2 proof-of-concept study of gevokizumab in subjects with inflammatory erosive osteoarthritis of the hand

Trial Profile

A phase 2 proof-of-concept study of gevokizumab in subjects with inflammatory erosive osteoarthritis of the hand

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Apr 2014

At a glance

  • Drugs Gevokizumab (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors XOMA
  • Most Recent Events

    • 03 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 23 Jul 2013 40 patients have been recruited so far, according to a media release from XOMA.
    • 26 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top